Chembio Diagnostics received CE Mark for point-of-care multiplex test for Zika, Dengue and Chikungunya
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
On May 23, 2019, the U.S. Food and Drug Administration (FDA) announced that it had authorized InBios’ marketing…
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
On Sept. 11, 2018, the U.S. Food and Drug Administration (FDA) had announced that it had received 510k…
On Jan. 12, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory…
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
In 2015, the state of Alaska Department of Health announced they had identified Alaskapox virus in a patient…
On Dec. 22, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILï¾®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckï¾’s…
On Dec. 12, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
On Sept. 30, 2014, the Centers for Disease Control and Prevention confirmed that Eric Duncan, a Liberian national…
On Sept. 3, 2014, OHSU announced it was awarded a $25 million grant from the Bill & Melinda…
On May 5, 2014, the WHO Director-General declared the international spread of wild poliovirus in 2014 a Public…
On Dec. 26, 2013, a 2-year-old boy in the remote Guinean village of Meliandou fell ill with a…
On Dec. 16, 2013, the Centers for Disease Control and Prevention (CDC) was informed by Merck that the…
In 2013, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center to investigate…
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
In 2012, Middle East Respiratory Syndrome (MERS), a viral respiratory illness, was first reported in Saudi Arabia in…
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
On Oct. 21, 2011, the Food and Drug Administration (FDA) announced it had approved revised prescribing information and…